References
Kwok CS, Nijjar RS, Loke YK. Effects of proton pump inhibitors on adverse gastrointestinal events in patients receiving clopidogrel: systematic review and meta-analysis. Drug Saf 2011; 34(1): 47–57
Kwok CS, Loke YK. Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel. Aliment Pharmacol Ther 2010; 31: 810–23
Van Boxel OS, van Oijen MG, Hagenaars MP, et al. Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study. Am J Gastroenterol 2010; 105: 2430–6
Acknowledgements
M.G.H. van Oijen has received unrestricted research grants from AstraZeneca and Janssen, and serves as a consultant for AstraZeneca and Pfizer. P.D. Siersema has received unrestricted research grants from AstraZeneca, Janssen and Nycomed, and serves as a consultant for AstraZeneca, Janssen, Movetis and Pfizer.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Oijen, M.G.H., Siersema, P.D. Effects of Proton Pump Inhibitors in Patients Receiving Clopidogrel. Drug-Safety 34, 173 (2011). https://doi.org/10.2165/11588430-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11588430-000000000-00000